Study of telitacicept for inflammatory myopathy
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This trial tests an investigational drug called telitacicept for people with inflammatory myopathy (muscle inflammation). It may help reduce muscle weakness and other symptoms when standard treatments haven't worked well enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with inflammatory myopathy.
- Standard treatments like steroids or immune-suppressing drugs have not worked well enough or caused too many side effects.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have active infections such as HIV, hepatitis B or C, tuberculosis, or recent COVID-19 infection.
- You have not had certain other biologic treatments within the last 3 months or IVIG/plasmapheresis within the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, telitacicept, for people with myasthenia gravis that only affects the eyes (ocular myasthenia gravis). The goal is to see if it can improve symptoms like droopy eyelids or double vision.
This trial is testing a new medication called telitacicept to see if it can help children with eye muscle weakness from myasthenia gravis. It aims to find a more effective and safe treatment for this condition, which can affect vision and daily activities.
This trial tests a new drug called telitacicept for people with lung scarring caused by connective tissue diseases. It aims to see if the drug can improve lung function and slow down the disease progression.
This trial tests a new drug called telitacicept combined with low-dose steroids for people with myasthenia gravis that hasn't improved with standard treatments. It aims to reduce muscle weakness and improve daily function.
This trial tests if a new medication, telitacicept, is safe and effective for people with difficult-to-treat rheumatoid arthritis. It may be an option for patients who have not found relief from other treatments.
This trial tests a new drug called telitacicept for people with rheumatoid arthritis (RA) that hasn't improved after trying multiple treatments. It aims to see if the drug can reduce joint pain and swelling when other medications have failed.
Hear when a new Inflammatory Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.